This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


User:Emma Wozniak/sandbox1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 5: Line 5:
1IWG is one component of a three-part AcrAB-TolC multidrug efflux pump system found in E. coli that works to maintain resistance against a range of antibiotics. This protein, which is also called the bacterial multidrug efflux transporter AcrB protein, works together with the AcrA and TolC proteins to capture and export any antibacterial compounds and detergents that can compromise the cell. 1IWG is the inner-membrane transporter protein in this system and has subunits that are present in both the cytoplasm and periplasm of the E. coli cell, which allows it to work in tandem with the TolC protein for drug export. It is believed that AcrB captures substrates mainly from the periplasm of the cell, but these substrates can still enter the inner cavity of this funnel-like protein from the cytoplasm.
1IWG is one component of a three-part AcrAB-TolC multidrug efflux pump system found in E. coli that works to maintain resistance against a range of antibiotics. This protein, which is also called the bacterial multidrug efflux transporter AcrB protein, works together with the AcrA and TolC proteins to capture and export any antibacterial compounds and detergents that can compromise the cell. 1IWG is the inner-membrane transporter protein in this system and has subunits that are present in both the cytoplasm and periplasm of the E. coli cell, which allows it to work in tandem with the TolC protein for drug export. It is believed that AcrB captures substrates mainly from the periplasm of the cell, but these substrates can still enter the inner cavity of this funnel-like protein from the cytoplasm.
-
<StructureSection load='1iwg' size='340' side='right'caption='[[1iwg]], [[Resolution|resolution]] 3.50&Aring;' scene=''>
+
 
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[1iwg]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/"bacillus_coli"_migula_1895 "bacillus coli" migula 1895]. The November 2007 RCSB PDB [https://pdb.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/index.html Molecule of the Month] feature on ''Multidrug Resistance Transporters'' by David S. Goodsell is [https://dx.doi.org/10.2210/rcsb_pdb/mom_2007_11 10.2210/rcsb_pdb/mom_2007_11]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1IWG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1IWG FirstGlance]. <br>
+
This protein has a molecular mass of 114 kDa and is a one chain structure that consists of 1049 amino acids, and organizes itself as a homotrimer in shape similar to that of a jellyfish. Each protomer in this protein is composed of a 50 A thick transmembrane region, as well as a protruding headpiece that is 70 A in size. It is believed by some that this headpiece section opens up at the top like a funnel, which the TolC protein can directly dock itself onto. Direct disulfide cross-linking experiments have also shown the interactions between the AcrB and TolC trimers, suggesting that the headpiece-TolC belief might be true.
-
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1iwg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1iwg OCA], [https://pdbe.org/1iwg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1iwg RCSB], [https://www.ebi.ac.uk/pdbsum/1iwg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1iwg ProSAT]</span></td></tr>
+
 
-
</table>
+
AcrB is shaped like a funnel with its ends found in both the cytoplasm and periplasm of the bacterial cell. The C terminus of AcrB is located in the cell’s cytoplasm, while the N terminus links with AcrA in the periplasm. The N- and C- terminal halves of AcrB are connected to each other with an alpha-helix that runs parallel to the cytoplasmic membrane of the bacteria. Subunits within the protein have three possible conformational states, which include the access (L), binding (T), and extrusion (O) states. However, binding of substrates and inhibitors will affect the conformational states of the protein. For example, binding of the MBX3132 inhibitor creates a TTT conformation state for the protein as a whole, which makes the inhibitor bind tightly to the protein and negatively affects substrate binding/protein function.
 +
 
 +
It has first been found that a Asp-Lys-Asp triad was found to be essential in AcrB. Later, three individual subunits in the transmembrane region have been identified to play key roles in AcrB function. The Asp407-Asp408 residue has been found to be essential in the TM4 subunit in E. coli, and this residue works in conjunction with the Thr978 residue in the TM11 and Lys940 residue of the TM10 subunits to allow the protein to function.
 +
 
== Function ==
== Function ==
[[https://www.uniprot.org/uniprot/ACRB_ECOLI ACRB_ECOLI]] AcrAB is a drug efflux protein with a broad substrate specificity.<ref>PMID:16915237</ref> <ref>PMID:16946072</ref> <ref>PMID:17194213</ref>
[[https://www.uniprot.org/uniprot/ACRB_ECOLI ACRB_ECOLI]] AcrAB is a drug efflux protein with a broad substrate specificity.<ref>PMID:16915237</ref> <ref>PMID:16946072</ref> <ref>PMID:17194213</ref>

Revision as of 18:46, 28 April 2022

Bacterial Multidrug Efflux Transporter AcrB (1IWG)

Efflux pump systems have evolved in bacteria to act as a chemotherapeutic drug and antibiotic resistance mechanism within the bacterial cytoplasmic membrane. These pump systems typically consist of multiple proteins that are embedded in the membranes and perisplasms of the bacterial cells, which all bond together to work to recognize and export foreign materials that have come in contact with the cell. They also play an essential role in biofilm formation of capable bacteria, and work to help provide protection and reduce the stress placed on the biofilm core.

1IWG is one component of a three-part AcrAB-TolC multidrug efflux pump system found in E. coli that works to maintain resistance against a range of antibiotics. This protein, which is also called the bacterial multidrug efflux transporter AcrB protein, works together with the AcrA and TolC proteins to capture and export any antibacterial compounds and detergents that can compromise the cell. 1IWG is the inner-membrane transporter protein in this system and has subunits that are present in both the cytoplasm and periplasm of the E. coli cell, which allows it to work in tandem with the TolC protein for drug export. It is believed that AcrB captures substrates mainly from the periplasm of the cell, but these substrates can still enter the inner cavity of this funnel-like protein from the cytoplasm.


Structural highlights

This protein has a molecular mass of 114 kDa and is a one chain structure that consists of 1049 amino acids, and organizes itself as a homotrimer in shape similar to that of a jellyfish. Each protomer in this protein is composed of a 50 A thick transmembrane region, as well as a protruding headpiece that is 70 A in size. It is believed by some that this headpiece section opens up at the top like a funnel, which the TolC protein can directly dock itself onto. Direct disulfide cross-linking experiments have also shown the interactions between the AcrB and TolC trimers, suggesting that the headpiece-TolC belief might be true.

AcrB is shaped like a funnel with its ends found in both the cytoplasm and periplasm of the bacterial cell. The C terminus of AcrB is located in the cell’s cytoplasm, while the N terminus links with AcrA in the periplasm. The N- and C- terminal halves of AcrB are connected to each other with an alpha-helix that runs parallel to the cytoplasmic membrane of the bacteria. Subunits within the protein have three possible conformational states, which include the access (L), binding (T), and extrusion (O) states. However, binding of substrates and inhibitors will affect the conformational states of the protein. For example, binding of the MBX3132 inhibitor creates a TTT conformation state for the protein as a whole, which makes the inhibitor bind tightly to the protein and negatively affects substrate binding/protein function.

It has first been found that a Asp-Lys-Asp triad was found to be essential in AcrB. Later, three individual subunits in the transmembrane region have been identified to play key roles in AcrB function. The Asp407-Asp408 residue has been found to be essential in the TM4 subunit in E. coli, and this residue works in conjunction with the Thr978 residue in the TM11 and Lys940 residue of the TM10 subunits to allow the protein to function.

Function

[ACRB_ECOLI] AcrAB is a drug efflux protein with a broad substrate specificity.[1] [2] [3]

Evolutionary Conservation

Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf.

Publication Abstract from PubMed

AcrB is a major multidrug exporter in Escherichia coli. It cooperates with a membrane fusion protein, AcrA, and an outer membrane channel, TolC. We have determined the crystal structure of AcrB at 3.5 A resolution. Three AcrB protomers are organized as a homotrimer in the shape of a jellyfish. Each protomer is composed of a transmembrane region 50 A thick and a 70 A protruding headpiece. The top of the headpiece opens like a funnel, where TolC might directly dock into AcrB. A pore formed by three alpha-helices connects the funnel with a central cavity located at the bottom of the headpiece. The cavity has three vestibules at the side of the headpiece which lead into the periplasm. In the transmembrane region, each protomer has twelve transmembrane alpha-helices. The structure implies that substrates translocated from the cell interior through the transmembrane region and from the periplasm through the vestibules are collected in the central cavity and then actively transported through the pore into the TolC tunnel.

Crystal structure of bacterial multidrug efflux transporter AcrB.,Murakami S, Nakashima R, Yamashita E, Yamaguchi A Nature. 2002 Oct 10;419(6907):587-93. PMID:12374972[4]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

  1. Murakami S, Nakashima R, Yamashita E, Matsumoto T, Yamaguchi A. Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature. 2006 Sep 14;443(7108):173-9. Epub 2006 Aug 16. PMID:16915237 doi:10.1038/nature05076
  2. Seeger MA, Schiefner A, Eicher T, Verrey F, Diederichs K, Pos KM. Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism. Science. 2006 Sep 1;313(5791):1295-8. PMID:16946072 doi:313/5791/1295
  3. Sennhauser G, Amstutz P, Briand C, Storchenegger O, Grutter MG. Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors. PLoS Biol. 2007 Jan;5(1):e7. PMID:17194213 doi:10.1371/journal.pbio.0050007
  4. Murakami S, Nakashima R, Yamashita E, Yamaguchi A. Crystal structure of bacterial multidrug efflux transporter AcrB. Nature. 2002 Oct 10;419(6907):587-93. PMID:12374972 doi:10.1038/nature01050

Contents

</StructureSection>

Proteopedia Page Contributors and Editors (what is this?)

Emma Wozniak

Personal tools